CMS Ruxolitinib Cream Approved in Singapore
Ruxolitinib phosphate cream has been approved in Singapore. The headline says the treatment addresses a gap in vitiligo care.
Related stories
Block Agrees in Principle to $764 Million DOJ Settlement
Block has agreed in principle to pay $764 million to resolve a federal investigation into alleged failures in its anti-money laundering controls.
M impact | REGULATION | Nov 04, 2026, 10:11 AM UTC
Tenneco Clean Air India Stamp Duty Penalty Raised to 243.59 Million Rupees
A collector reconfirmed stamp duty and enhanced the penalty to 243.59 million rupees.
M impact | REGULATION | Nov 04, 2026, 10:09 AM UTC
Lai Fung Public Float at 14.76%, Below Required 25%
Lai Fung's public float was 14.76% as of Nov. 4, 2026, below the required 25%.
L impact | REGULATION | Nov 04, 2026, 09:52 AM UTC
Police seek arrest warrant for NongHyup chairman Kang Ho-dong
Police sought an arrest warrant for NongHyup chairman Kang Ho-dong over alleged bribery and other charges.
M impact | REGULATION | Nov 04, 2026, 09:48 AM UTC
India Approves $297 Million Critical Minerals Processing Incentives
India approved a $297 million incentive policy for critical minerals processing.
M impact | REGULATION | Nov 04, 2026, 09:42 AM UTC
India Cabinet Approves $1.53 Billion Energy Storage Programme
The cabinet approved 145 billion rupees ($1.53 billion) for a programme to develop energy storage projects in India, Information Minister Ashwini Vaishnaw said.
M impact | REGULATION | Nov 04, 2026, 09:26 AM UTC